CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
about
A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival.The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma.To Each Its Own: Linking the Biology and Epidemiology of NHL Subtypes.Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma.C-X-C chemokine receptor type 5 gene polymorphism affects gene expression in CD4+ T cells and is associated with increased risk of colorectal cancer.The role of G protein-coupled receptors in lymphoid malignancies.Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis.
P2860
Q35311162-93F68962-D243-40D1-BD4A-94C37D9298E0Q35607281-D1FF80FF-78F3-4BC0-91B9-8CF431F333B1Q38391516-541C5969-3551-4FFC-B5D7-7D5D584B8338Q38516259-1D3574A2-3013-46BD-8271-B2E04850600EQ38536210-ABC8D797-4005-4B87-AEB2-3AD8ABE45B4BQ41768870-C6965321-3F1C-42B1-A07E-1D353489C0C3Q46234976-DD781315-D497-4C93-AEEA-64674C34B5EDQ47960121-B3249BC1-05B4-4805-B154-7E76F324AB09Q50099990-C6AF5D6D-EA90-4822-99AA-1F782151442AQ50449771-64FCD0EC-3169-443D-AA15-DEE9F5C1D837
P2860
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
@en
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
@nl
type
label
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
@en
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
@nl
prefLabel
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
@en
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
@nl
P2093
P2860
P1476
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
@en
P2093
Ahmet Dogan
Alice H Wang
Andrew L Feldman
Brian K Link
Bridget Charbonneau
Clive S Zent
George J Weiner
James R Cerhan
Matthew J Maurer
Nazan Ozsan
P2860
P2888
P304
P356
10.1007/S00262-013-1452-4
P577
2013-06-28T00:00:00Z